Oral care compositions containing deoxy sugar antimetabolites

US11471394B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11471394-B2
Application numberUS-202016884958-A
CountryUS
Kind codeB2
Filing dateMay 27, 2020
Priority dateMar 15, 2013
Publication dateOct 18, 2022
Grant dateOct 18, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are oral care compositions comprising a deoxy sugar antimetabolite and methods of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in a subject.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in the oral cavity of a subject comprising administering to the subject an oral care composition comprising a deoxy sugar antimetabolite with no additional antibacterial agent and an orally acceptable carrier, wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.005% to 0.7% based on the total weight of the composition, wherein bacteria is decreased by less than 5% and biofilm is inhibited by at least 25%, and wherein the deoxy sugar antimetabolite is selected from the group consisting of 6-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, 2-amino-2-deoxy-D-mannosamine, and mixtures thereof. 2. The method of claim 1 , wherein the deoxy sugar antimetabolite is selected from the group consisting of 6-deoxy-D-glucose, 2-fluoro-2-deoxy-D-glucose, and mixtures thereof. 3. The method of claim 1 , wherein the deoxy sugar antimetabolite is 2-amino-2-deoxy-D-mannosamine. 4. The method of claim 1 , wherein the biofilm efficiency is at least 1000%. 5. The method according to claim 1 , wherein the method comprises treats a disease condition of the oral cavity by inhibiting microbial biofilm formation and/or degrading a microbial biofilm in the oral cavity which is selected from the group consisting of dental plaque, tooth decay, periodontal disease and gingivitis. 6. The method according to claim 1 , wherein the biofilm is formed from one or more species of bacteria selected from Actinomyces viscosus, Actinomyces naeslundii, Lactobacillus casei, Streptococcus oralis, Fusobacterium nucleatum and Veillonella parvula , and Porphyromonas gingivalis. 7. The method of claim 1 , wherein the deoxy sugar antimetabolite is 6-deoxy-D-glucose. 8. The method of claim 1 , wherein the deoxy sugar antimetabolite is 2-fluoro-2-deoxy-D-glucose. 9. The method of claim 1 , wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.005% to 0.5% based on the total weight of the composition. 10. The method of claim 1 , wherein the deoxy sugar antimetabolite is present in the composition at a concentration of from 0.008% to 0.3% based on the total weight of the composition.

Assignees

Inventors

Classifications

  • Antibacterial agents · CPC title

  • Local antiseptics · CPC title

  • to halogen · CPC title

  • Aminosugars · CPC title

  • Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11471394B2 cover?
Described herein are oral care compositions comprising a deoxy sugar antimetabolite and methods of inhibiting microbial biofilm formation and/or degrading a microbial biofilm in a subject.
Who is the assignee on this patent?
Colgate Palmolive Co, The Forsyth Inst
What technology area does this patent fall under?
Primary CPC classification A61K8/60. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).